$VERU
VERU INC.

2021 Q4 Form 10-Q Financial Statement

#000086389422000003 Filed on February 09, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $14.14M $14.62M
YoY Change -3.3% 38.18%
Cost Of Revenue $2.293M $3.780M
YoY Change -39.34% 14.25%
Gross Profit $11.84M $10.84M
YoY Change 9.28% 49.08%
Gross Profit Margin 83.78% 74.14%
Selling, General & Admin $6.723M $4.382M
YoY Change 53.43% 16.74%
% of Gross Profit 56.77% 40.44%
Research & Development $10.08M $5.678M
YoY Change 77.56% 7.13%
% of Gross Profit 85.13% 52.39%
Depreciation & Amortization $25.00K $32.00K
YoY Change -21.88% -73.33%
% of Gross Profit 0.21% 0.3%
Operating Expenses $16.80M $10.06M
YoY Change 67.05% 11.11%
Operating Profit -$4.962M $19.19M
YoY Change -125.86% -1175.28%
Interest Expense $1.159M $1.189M
YoY Change -2.56% 4.18%
% of Operating Profit 6.2%
Other Income/Expense, Net -$1.303M -$1.881M
YoY Change -30.73% 17.76%
Pretax Income -$6.265M $17.31M
YoY Change -136.2% -611.73%
Income Tax $114.7K $78.30K
% Of Pretax Income 0.45%
Net Earnings -$6.380M $17.23M
YoY Change -137.03% -621.25%
Net Earnings / Revenue -45.14% 117.86%
Basic Earnings Per Share -$0.08 $0.25
Diluted Earnings Per Share -$0.08 $0.23
COMMON SHARES
Basic Shares Outstanding 80.02M 70.31M
Diluted Shares Outstanding 80.02M 75.80M

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.1M $30.90M
YoY Change 275.74% 635.71%
Cash & Equivalents $116.1M $30.92M
Short-Term Investments
Other Short-Term Assets $14.13M $3.300M
YoY Change 328.22% 57.14%
Inventory $4.900M $6.666M
Prepaid Expenses
Receivables $8.072M $4.156M
Other Receivables $2.500M $2.500M
Total Short-Term Assets $145.7M $47.57M
YoY Change 206.32% 182.87%
LONG-TERM ASSETS
Property, Plant & Equipment $869.4K $288.0K
YoY Change 201.89% -14.33%
Goodwill $6.900M $6.879M
YoY Change 0.31%
Intangibles $4.031M $4.102M
YoY Change -1.74% -79.58%
Long-Term Investments
YoY Change
Other Assets $878.4K $10.20M
YoY Change -91.39% 1409.08%
Total Long-Term Assets $26.46M $25.23M
YoY Change 4.86% -33.11%
TOTAL ASSETS
Total Short-Term Assets $145.7M $47.57M
Total Long-Term Assets $26.46M $25.23M
Total Assets $172.2M $72.80M
YoY Change 136.49% 33.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.088M $3.275M
YoY Change 24.82% -13.82%
Accrued Expenses $6.214M $6.500M
YoY Change -4.4% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.601M $7.300M
YoY Change -50.67% 10.61%
Total Short-Term Liabilities $13.94M $17.06M
YoY Change -18.3% 0.96%
LONG-TERM LIABILITIES
Long-Term Debt $9.619M $6.000M
YoY Change 60.31% -10.45%
Other Long-Term Liabilities $14.99K $18.24K
YoY Change -17.84% -49.2%
Total Long-Term Liabilities $14.99K $18.24K
YoY Change -17.84% -49.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.94M $17.06M
Total Long-Term Liabilities $14.99K $18.24K
Total Liabilities $24.16M $24.04M
YoY Change 0.5% -3.45%
SHAREHOLDERS EQUITY
Retained Earnings -$88.18M -$71.96M
YoY Change 22.53% -2.12%
Common Stock $822.3K $740.9K
YoY Change 10.99% 10.22%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.807M $7.807M
YoY Change 0.0% 0.0%
Treasury Stock Shares $2.184M $2.184M
Shareholders Equity $148.0M $48.75M
YoY Change
Total Liabilities & Shareholders Equity $172.2M $72.79M
YoY Change 136.53% 33.56%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income -$6.380M $17.23M
YoY Change -137.03% -621.25%
Depreciation, Depletion And Amortization $25.00K $32.00K
YoY Change -21.88% -73.33%
Cash From Operating Activities -$8.658M $659.2K
YoY Change -1413.3% -126.26%
INVESTING ACTIVITIES
Capital Expenditures $302.2K $7.186K
YoY Change 4105.52% -67.05%
Acquisitions
YoY Change
Other Investing Activities $2.500M $15.00M
YoY Change -83.33%
Cash From Investing Activities $2.198M $14.99M
YoY Change -85.34% -68852.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 204.4K 1.681M
YoY Change -87.84% 307.82%
NET CHANGE
Cash From Operating Activities -8.658M 659.2K
Cash From Investing Activities 2.198M 14.99M
Cash From Financing Activities 204.4K 1.681M
Net Change In Cash -6.256M 17.33M
YoY Change -136.09% -917.51%
FREE CASH FLOW
Cash From Operating Activities -$8.658M $659.2K
Capital Expenditures $302.2K $7.186K
Free Cash Flow -$8.960M $652.1K
YoY Change -1474.12% -125.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000863894
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
1-13602
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
Veru Inc.
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WI
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-1144397
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
48 NW 25th Street
CY2021Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33127
CY2021Q4 dei City Area Code
CityAreaCode
305
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
509-6897
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2021Q4 dei Trading Symbol
TradingSymbol
VERU
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80050349
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116103961
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
122359535
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8071541
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8794224
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2500000
CY2021Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
5000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4899868
CY2021Q3 us-gaap Inventory Net
InventoryNet
5574253
CY2021Q4 veru Prepaid Research And Development Costs Current
PrepaidResearchAndDevelopmentCostsCurrent
12191149
CY2021Q3 veru Prepaid Research And Development Costs Current
PrepaidResearchAndDevelopmentCostsCurrent
9174586
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1940149
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
850889
CY2021Q4 us-gaap Assets Current
AssetsCurrent
145706668
CY2021Q3 us-gaap Assets Current
AssetsCurrent
151753487
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
869442
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
592603
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
869017
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
969839
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12931129
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13024550
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4030952
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4048810
CY2021Q4 us-gaap Goodwill
Goodwill
6878932
CY2021Q3 us-gaap Goodwill
Goodwill
6878932
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
878417
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
878502
CY2021Q4 us-gaap Assets
Assets
172164557
CY2021Q3 us-gaap Assets
Assets
178146723
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4087708
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3409771
CY2021Q4 veru Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
2179926
CY2021Q3 veru Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
2020445
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2016830
CY2021Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
4986058
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1589111
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1615922
CY2021Q4 veru Residual Royalty Agreement Current
ResidualRoyaltyAgreementCurrent
3601007
CY2021Q3 veru Residual Royalty Agreement Current
ResidualRoyaltyAgreementCurrent
3237211
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
465921
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
497903
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13940503
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15767310
CY2021Q4 veru Residual Royalty Agreement Noncurrent
ResidualRoyaltyAgreementNoncurrent
9618698
CY2021Q3 veru Residual Royalty Agreement Noncurrent
ResidualRoyaltyAgreementNoncurrent
9397136
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
522709
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
609921
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63426
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63426
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14986
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14986
CY2021Q4 us-gaap Liabilities
Liabilities
24160322
CY2021Q3 us-gaap Liabilities
Liabilities
25852779
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
154000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
154000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82232786
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82153452
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80049082
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79969748
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
822328
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
821535
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243748215
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
241658711
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-581519
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-581519
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88178184
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81798178
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2183704
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2183704
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7806605
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
7806605
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
148004235
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
152293944
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
172164557
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178146723
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14135132
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14616989
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2293050
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3780356
CY2021Q4 us-gaap Gross Profit
GrossProfit
11842082
CY2020Q4 us-gaap Gross Profit
GrossProfit
10836633
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10081161
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5677754
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6723206
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4381880
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
16804367
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
10059634
CY2020Q4 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
18410158
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4962285
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19187157
CY2021Q4 us-gaap Interest Expense
InterestExpense
1158682
CY2020Q4 us-gaap Interest Expense
InterestExpense
1189183
CY2021Q4 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-209000
CY2020Q4 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-604000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64616
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87971
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1303066
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1881154
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6265351
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17306003
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114655
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78302
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6380006
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
17227701
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80023168
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70313589
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80023168
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75799037
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
152293944
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1880428
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
209869
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6380006
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
148004235
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
30111316
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
785297
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
623819
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
17227701
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
48748133
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6380006
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
17227701
CY2021Q4 veru Depreciation And Other Amortization
DepreciationAndOtherAmortization
43228
CY2020Q4 veru Depreciation And Other Amortization
DepreciationAndOtherAmortization
91783
CY2021Q4 veru Operating Lease Right Of Use Assets Non Cash Change
OperatingLeaseRightOfUseAssetsNonCashChange
100822
CY2020Q4 veru Operating Lease Right Of Use Assets Non Cash Change
OperatingLeaseRightOfUseAssetsNonCashChange
91762
CY2021Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-376358
CY2020Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-92793
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1880428
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
785297
CY2020Q4 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
18410158
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93421
CY2020Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
37502
CY2021Q4 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-209000
CY2020Q4 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-604000
CY2021Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-52776
CY2020Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
9138
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-724683
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1071445
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-725161
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-29088
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4105738
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1825459
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
677937
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
462183
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2831116
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
447101
CY2021Q4 veru Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-119194
CY2020Q4 veru Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-54935
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8657792
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
659241
CY2021Q4 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2500000
CY2020Q4 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
15000000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
302209
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7186
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2197791
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14992814
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
209869
CY2020Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
623819
CY2020Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1061442
CY2021Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5442
CY2020Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4598
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
204427
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1680663
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6255574
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17332718
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
122359535
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13588778
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116103961
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30921496
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
782324
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
1096390
CY2020Q4 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
5000000
CY2021Q4 us-gaap Basis Of Accounting
BasisOfAccounting
Note 1 – Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (“we,” “our,” “us,” “Veru” or the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. The accompanying condensed consolidated balance sheet as of September 30, 2021 has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations and cash flows for the three months ended December 31, 2021 are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending September 30, 2022. The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented. Principles of consolidation and nature of operations: Veru Inc. is referred to in these notes collectively with its subsidiaries as “we,” “our,” “us,” “Veru” or the “Company.” The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (APP) and The Female Health Company Limited, and The Female Health Company Limited’s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the “U.K. subsidiary”), and The Female Health Company (UK) plc’s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the “Malaysia subsidiary”). All significant intercompany transactions and accounts have been eliminated in consolidation. The Company is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancers. The Company has two operating segments: the Pharmaceuticals segment (previously referred to as the Research and Development segment) and the FC2 segment (previously referred to as the Sexual Health Business segment). The Pharmaceuticals segment includes activities related to multiple drug products under clinical development and ENTADFI™, a new treatment for benign prostatic hyperplasia that was approved by the FDA in December 2021. The FC2 segment includes the FC2 Female Condom/FC2 Internal Condom® (FC2), an FDA-approved product for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. All of the Company’s net revenues during the three months ended December 31, 2021 and most of the Company’s net revenues during the three months ended December 31, 2020 were derived from sales of FC2. Reclassifications: Certain prior period amounts on the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. These reclassifications had no effect on the results of operations or financial position for any period presented. Other comprehensive (loss) income: Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net (loss) income. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net (loss) income, are components of other comprehensive loss. For the three months ended December 31, 2021 and 2020, comprehensive (loss) income is equivalent to the reported net (loss) income. Recently adopted accounting pronouncements: In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes. The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 on a prospective basis effective October 1, 2021. The adoption of ASU 2019-12 did not impact our consolidated financial statements and related disclosures.  
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Reclassifications: Certain prior period amounts on the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. These reclassifications had no effect on the results of operations or financial position for any period presented.
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7851000
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4182000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
209000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
604000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8060000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4786000
CY2021Q4 us-gaap Revenues
Revenues
14135132
CY2020Q4 us-gaap Revenues
Revenues
14616989
CY2021Q4 us-gaap Revenues
Revenues
14135132
CY2021Q4 us-gaap Revenues
Revenues
14135132
CY2020Q4 us-gaap Revenues
Revenues
14616989
CY2020Q4 us-gaap Revenues
Revenues
14616989
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
38000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
132000
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
8174710
CY2021Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
8938849
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18643
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20643
CY2021Q4 veru Allowance For Sales And Payment Term Discounts
AllowanceForSalesAndPaymentTermDiscounts
84526
CY2021Q3 veru Allowance For Sales And Payment Term Discounts
AllowanceForSalesAndPaymentTermDiscounts
123982
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
8071541
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8794224
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4467985
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4165776
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3598543
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3573173
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
869442
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
592603
CY2021Q4 us-gaap Depreciation
Depreciation
25000
CY2020Q4 us-gaap Depreciation
Depreciation
32000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
369048
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4030952
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4400000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
351190
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4048810
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60000
CY2021Q3 us-gaap Goodwill
Goodwill
6900000
CY2021Q4 us-gaap Goodwill
Goodwill
6900000
CY2020Q4 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021Q4 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
572860
CY2021Q4 us-gaap Accretion Expense
AccretionExpense
1158682
CY2020Q4 us-gaap Accretion Expense
AccretionExpense
602858
CY2020Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13465
CY2021Q4 us-gaap Interest Expense
InterestExpense
1158682
CY2020Q4 us-gaap Interest Expense
InterestExpense
1189183
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7419354
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
15.50
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
108000000.0
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1880428
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
785297
CY2021Q4 veru Stock Option Conversion Ratio
StockOptionConversionRatio
1
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
210000
CY2020Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
624000
CY2020Q3 us-gaap Security Deposit
SecurityDeposit
117000
CY2020Q4 us-gaap Security Deposit
SecurityDeposit
117000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2178
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2178
CY2021Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
256
CY2020Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
939
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
131110
CY2020Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
135326
CY2021Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
12771
CY2020Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1863
CY2021Q4 us-gaap Variable Lease Cost
VariableLeaseCost
46019
CY2020Q4 us-gaap Variable Lease Cost
VariableLeaseCost
36683
CY2021Q4 us-gaap Sublease Income
SubleaseIncome
44844
CY2020Q4 us-gaap Sublease Income
SubleaseIncome
44845
CY2021Q4 us-gaap Lease Cost
LeaseCost
147490
CY2020Q4 us-gaap Lease Cost
LeaseCost
132144
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
153000
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
143000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.139
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.139
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 veru Product Liability Insurance Coverage Amount
ProductLiabilityInsuranceCoverageAmount
20000000.0
CY2021Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1315724
CY2020Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3634260
CY2021Q4 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-101875
CY2020Q4 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
281396
CY2021Q4 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
257196
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-23350
CY2020Q4 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-64290
CY2020Q4 veru Effective Income Tax Rate Reconciliation Effect Of Warrants Exercised
EffectiveIncomeTaxRateReconciliationEffectOfWarrantsExercised
-2038919
CY2020Q4 veru Cares Act Effective Income Tax Rate Reconciliation Effect Of Paycheck Protection Program Funds
CaresActEffectiveIncomeTaxRateReconciliationEffectOfPaycheckProtectionProgramFunds
95886
CY2021Q4 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1963430
CY2021Q4 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-29761
CY2020Q4 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-32570
CY2021Q4 veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
88267
CY2020Q4 veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
125145
CY2021Q4 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3089596
CY2020Q4 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1732786
CY2021Q4 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
113736
CY2020Q4 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1952
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114655
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78302
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8615379
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8209224
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1690488
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1646827
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
15782126
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
15875889
CY2021Q4 veru Deferred Tax Assets Foreign Capital Allowance
DeferredTaxAssetsForeignCapitalAllowance
117709
CY2021Q3 veru Deferred Tax Assets Foreign Capital Allowance
DeferredTaxAssetsForeignCapitalAllowance
117709
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4724845
CY2021Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2761415
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2417046
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2071838
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1630267
CY2021Q3 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1368042
CY2021Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
1072714
CY2021Q3 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
1025425
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
36455738
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33463604
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22669607
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19580011
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13786131
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13883593
CY2021Q4 veru Deferred Tax Liabilities In Process R And D
DeferredTaxLiabilitiesInProcessRAndD
882427
CY2021Q3 veru Deferred Tax Liabilities In Process R And D
DeferredTaxLiabilitiesInProcessRAndD
882427
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
29630
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
33671
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
918428
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
922469
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12867703
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12961124
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12931129
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13024550
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63426
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63426
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6380006
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
17227701
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80023168
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70313589
CY2020Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1025580
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5485448
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80023168
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75799037
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000
CY2021Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0000863894-22-000003-index-headers.html Edgar Link pending
0000863894-22-000003-index.html Edgar Link pending
0000863894-22-000003.txt Edgar Link pending
0000863894-22-000003-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veru-20211231.xsd Edgar Link pending
veru-20211231x10q.htm Edgar Link pending
veru-20211231x10q_htm.xml Edgar Link completed
veru-20211231xex31_1.htm Edgar Link pending
veru-20211231xex31_2.htm Edgar Link pending
veru-20211231xex32_1.htm Edgar Link pending
veru-20211231_cal.xml Edgar Link unprocessable
veru-20211231_def.xml Edgar Link unprocessable
veru-20211231_lab.xml Edgar Link unprocessable
veru-20211231_pre.xml Edgar Link unprocessable